TY  - JOUR

T1  - Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - PharmacoEconomics

UR  - https://eprints.whiterose.ac.uk/128751/

PY  - 2018/09/01

AU  - Uttley L

AU  - Bermejo I

AU  - Ren S

AU  - Martyn-St James M

AU  - Wong R

AU  - Scott DL

AU  - Young A

AU  - Stevenson M

ED  - 

DO  - DOI: 10.1007/s40273-018-0639-0

PB  - Springer Science and Business Media LLC

VL  - 36

IS  - 9

SP  - 1063

EP  - 1072

Y2  - 2024/09/20

ER  -